Literature DB >> 16004850

Role of anti-infective strategies in the prevention of stroke.

Armin J Grau1.   

Abstract

Case-control studies and a few prospective studies have indicated that chronic infections may add to the risk of stroke and that acute infections may act as trigger factors for stroke. Such chronic infections include periodontal disease, infection with Chlamydia pneumoniae or Helicobacter pylori, and chronic bronchitis. A causal role of these infectious diseases has not been proved, given conflicting study results, possible residual confounding in observational studies, and the lack of evidence from interventional trials. Therefore, special treatment regimens for stroke prevention based on serologic or genomic evidence of infection are not indicated outside of randomized studies at present. However, the preliminary available evidence suggests that in patients with previous cerebral ischemia, clinically diagnosed chronic infections should be taken seriously and should receive the treatment that is indicated according to current guidelines. This may include appropriate treatment of moderate or severe periodontitis and of chronic bronchitis. Inflammatory parameters (eg, C-reactive protein, leukocyte count, fibrinogen) are independently associated with the risk of first or recurrent stroke. The question of whether these indexes are causally related to stroke or merely represent risk markers is not sufficiently clarified. Their use in monitoring individual risk in daily clinical practice is limited at present by the lack of clearly defined therapeutic strategies to modify these parameters, although statins and other drugs can influence inflammatory markers. Observational studies have shown that influenza vaccination is significantly and independently associated with a reduced risk of stroke and myocardial infarction. Although interventional studies in stroke are lacking, it is recommendable that in accordance with current guidelines patients with previous vascular disease, including stroke, patients with high risk of stroke, and all subjects above age 60, receive an influenza vaccination annually.

Entities:  

Year:  2005        PMID: 16004850     DOI: 10.1007/s11936-005-0047-6

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  29 in total

1.  Association between influenza vaccination and reduced risk of brain infarction.

Authors:  Philippa Lavallée; Véronique Perchaud; Marion Gautier-Bertrand; David Grabli; Pierre Amarenco
Journal:  Stroke       Date:  2002-02       Impact factor: 7.914

Review 2.  Emerging concepts in periodontal therapy.

Authors:  Henry Greenwell; Nabil F Bissada
Journal:  Drugs       Date:  2002       Impact factor: 9.546

3.  Progression of early carotid atherosclerosis is only temporarily reduced after antibiotic treatment of Chlamydia pneumoniae seropositivity.

Authors:  Dirk Sander; Kerstin Winbeck; Jürgen Klingelhöfer; Thorleif Etgen; Bastian Conrad
Journal:  Circulation       Date:  2004-02-09       Impact factor: 29.690

4.  Relationship between periodontal disease, tooth loss, and carotid artery plaque: the Oral Infections and Vascular Disease Epidemiology Study (INVEST).

Authors:  Moïse Desvarieux; Ryan T Demmer; Tatjana Rundek; Bernadette Boden-Albala; David R Jacobs; Panos N Papapanou; Ralph L Sacco
Journal:  Stroke       Date:  2003-07-31       Impact factor: 7.914

5.  No evidence of involvement of Chlamydia pneumoniae in severe cerebrovascular atherosclerosis by means of quantitative real-time polymerase chain reaction.

Authors:  Petra Apfalter; Wolfgang Barousch; Marion Nehr; Birgit Willinger; Manfred Rotter; Alexander M Hirschl
Journal:  Stroke       Date:  2004-07-15       Impact factor: 7.914

6.  Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events.

Authors:  P M Ridker; N Rifai; M Clearfield; J R Downs; S E Weis; J S Miles; A M Gotto
Journal:  N Engl J Med       Date:  2001-06-28       Impact factor: 91.245

7.  Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment.

Authors:  J Gieffers; H Füllgraf; J Jahn; M Klinger; K Dalhoff; H A Katus; W Solbach; M Maass
Journal:  Circulation       Date:  2001-01-23       Impact factor: 29.690

8.  Presence of Chlamydia pneumoniae in human symptomatic and asymptomatic carotid atherosclerotic plaque.

Authors:  R LaBiche; D Koziol; T C Quinn; C Gaydos; S Azhar; G Ketron; S Sood; T J DeGraba
Journal:  Stroke       Date:  2001-04       Impact factor: 7.914

9.  The relationship between chronic H. pylori infection, CagA seropositivity and stroke: meta-analysis.

Authors:  Filippo Cremonini; Maurizio Gabrielli; Giovanni Gasbarrini; Paolo Pola; Antonio Gasbarrini
Journal:  Atherosclerosis       Date:  2004-04       Impact factor: 5.162

10.  Macrolide therapy for Chlamydia pneumoniae in the secondary prevention of coronary artery disease: a meta-analysis of randomized controlled trials.

Authors:  Mahyar Etminan; Bruce Carleton; J A C Delaney; Raj Padwal
Journal:  Pharmacotherapy       Date:  2004-03       Impact factor: 4.705

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.